Overview

Silodosin vs Placebo in the Treatment of Female LUTS

Status:
Not yet recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
This trial will be conducted to study the efficacy and safety of Silodosin in the treatment of female lower urinary tract symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
Mansoura University
Collaborator:
Amiri Hospital
Treatments:
Silodosin